Reneo Pharmaceuticals, Inc. (RPHM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 1.73 |
| Open | 1.68 |
| Day High | 18.2 |
| Day Low | 1.68 |
| 52-Week High | 82.9 |
| 52-Week Low | 1.68 |
| Volume | 437,523 |
| Average Volume | 17,983 |
| Market Cap | 60.84M |
| PE | -1.08 |
| EPS | -16.8 |
| Moving Average 50 Days | 14.92 |
| Moving Average 200 Days | 16.09 |
| Change | 16.47 |
Data not available
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
GlobeNewswire Inc.
Oct 04, 2024 8:57 PM GMT
-- OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in breast cancer -- On track to announce early clinical data for its lead program, OKI-219, in Q4-2024 -- P
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
GlobeNewswire Inc.
Oct 03, 2024 12:20 AM GMT
– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM) (“Reneo”) today announced the results of